Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria

Area of Science:

• Nephrology
• Urology
• Metabolic Diseases

Background:

• Primary hyperoxaluria type 3 (PH13) is characterized by nephrolithiasis and hyperoxaluria.
• Factors influencing stone formation in PH13 are not well understood.
• This study investigates stone events and related factors in PH13 patients.

Purpose of the Study:

• To characterize stone events in primary hyperoxaluria type 3.
• To examine associations between urine parameters and kidney function with stone formation in PH13.
• To understand the lifelong burden of stones in PH13.

Main Methods:

• Retrospective analysis of clinical and laboratory data from 70 PH13 patients.
• Data sourced from the Rare Kidney Stone Consortium Primary Hyperoxaluria Registry.
• Analysis included stone characteristics, clinical events, urine parameters, and kidney function.

Main Results:

• 93% of PH13 patients experienced kidney stones, with a median of 4 stones at first imaging.
• 89% had clinical stone events, with a median of 3 events per patient; 42.6% required surgery.
• Higher calcium oxalate supersaturation correlated with increased stone event rates; kidney function declined by the fourth decade.

Conclusions:

• Kidney stones represent a significant lifelong burden for PH13 patients.
• Reducing urinary calcium oxalate supersaturation is a potential strategy to decrease stone event frequency.
• Interventions targeting calcium oxalate supersaturation may reduce the need for surgical intervention in PH13.